Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the katG 315T mutation

Eur Respir J. 2017 Oct 12;50(4):1701752. doi: 10.1183/13993003.01752-2017. Print 2017 Oct.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents
  • Bacterial Proteins / genetics
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Extensively Drug-Resistant Tuberculosis*
  • Humans
  • Isoniazid*
  • Microbial Sensitivity Tests
  • Mutation / drug effects
  • Mycobacterium tuberculosis / drug effects
  • Tuberculosis, Multidrug-Resistant

Substances

  • Antitubercular Agents
  • Bacterial Proteins
  • Isoniazid